*Neisseria gonorrhoeae*
=======================

.. container:: justify-text

   *Neisseria gonorrhoeae* data are sourced from `Pathogenwatch <https://doi.org/10.1186/s13073-021-00858-2>`__, which calls AMR and lineage `genotypes <https://pubmlst.org/neisseria/>`_ (`MLST <https://doi.org/10.1186/1741-7007-5-35>`_, `NG-MAST <https://doi.org/10.1086/383047>`_) from genomes assembled from public data. The prevalence estimates shown are calculated using genome collections derived from non-targeted sampling frames (i.e. surveillance and burden studies, as opposed to AMR focused studies or outbreak investigations). These include EuroGASP `2013 <https://doi.org/10.1016/s1473-3099(18)30225-1>`_ & `2018 <https://doi.org/10.1016/s2666-5247(22)00044-1>`_, and several national surveillance studies. Last update: 5 August 2025.

Variable definitions
~~~~~~~~~~~~~~~~~~~~~~~~

.. container:: justify-text

   - **Genotypes**: sequence types from the `7-locus MLST scheme <https://doi.org/10.1128/jcm.43.8.4178-4182.2005>`_ for *Neisseria*, or 2-locus *N. gonorrhoeae* multi-antigen sequence typing (`NG-MAST <https://doi.org/10.1086/383047>`_) scheme, both hosted by `PubMLST <https://pubmlst.org/neisseria/>`_.
   - **AMR determinants** are identified by Pathogenwatch using an inhouse dictionary developed and maintained in consultation with an expert advisory group, described `here <https://doi.org/10.1186/s13073-021-00858-2>`__.
   - **AMR determinants within genotypes** - This plot shows combinations of determinants that result in clinical resistance to Azithromycin or Ceftriaxone, as defined in Figure 3 of `Sánchez-Busó et al (2021) <https://doi.org/10.1186/s13073-021-00858-2>`_.
   - **Susceptible to cat I/II drugs** - No determinants found for Azithromycin, Ceftriaxone, Cefixime (category I) or Benzylpenicillin, Ciprofloxacin, Spectinomycin (category II).

Abbreviations
~~~~~~~~~~~~~~

.. container:: justify-text

   - **MDR**: multidrug resistant (Resistant to one of Azithromycin / Ceftriaxone / Cefixime [category I representatives], plus two or more of Benzylpenicillin / Ciprofloxacin / Spectinomycin [category II representatives])
   - **XDR**: extensively drug resistant (Resistant to two of Azithromycin / Ceftriaxone / Cefixime [category I representatives], plus three of Benzylpenicillin / Ciprofloxacin / Spectinomycin [category II representatives])

   .. note::

      These definitions are based on those defined in the `European CDC Response Plan <https://www.ecdc.europa.eu/sites/default/files/documents/multi-and-extensively-drug-resistant-gonorrhoea-response-plan-Europe-2019.pdf>`_, modified to use the specific representatives of category I and II antibiotic classes that are available in the dashboard.


The data are collated from studies with the following PubMed IDs

.. list-table:: 
   :header-rows: 1

   * - **Study accession**
     - **PMID**
   * - PRJEB58139
     - 38614111
   * - PRJEB4024
     - 32013864
   * - PRJEB4024
     - 31358980
   * - PRJNA266539
     - 25378573
   * - PRJNA298332
     - 26935729
   * - PRJEB7904
     - 27638945
   * - PRJNA348107
     - 28510723
   * - PRJEB23008
     - 29523496
   * - PRJEB14168
     - 28348871
   * - PRJNA209340, PRJNA209376, PRJNA209345, PRJNA209319, PRJNA209352
       PRJNA209333, PRJNA209347, PRJNA209316, PRJNA209466, PRJNA209373
       PRJNA209465, PRJNA209351, PRJNA209342, PRJNA209343, PRJNA209320
       PRJNA209470
     - 25780762
   * - PRJEB17738
     - 29247013
   * - PRJEB10104
     - 29701830
   * - PRJDB6504,PRJDB6496
     - 30063202
   * - PRJEB34425
     - 32068837
   * - PRJEB10016
     - 32829411
   * - PRJNA392203
     - 29367612
   * - PRJNA473385
     - 29882175
   * - PRJEB19989
     - 31978353
   * - PRJEB9227
     - 29776807
   * - PRJNA394216
     - 29182725
   * - PRJNA317462
     - 30788502
   * - PRJEB14933
     - 26601852
   * - PRJEB32435
     - 33200978
   * - PRJNA315363
     - 27427203
   * - PRJEB34425
     - 32068837
   * - PRJNA317462, PRJNA329501
     - 32071056
   * - PRJEB32435
     - 32213251
   * - PRJNA520805
     - 31488838
   * - PRJEB34068
     - 35659907

